Medical Cannabis for Arthritis in the UK: A Guide to Options and Eligibility

If you have been living with a chronic, painful condition like osteoarthritis or rheumatoid arthritis, you have likely navigated a complex path of NHS treatments. In recent years, you may have noticed an increase in news coverage regarding "medical cannabis" and services such as those found on the releaf.co.uk arthritis page. With so much information—and misinformation—circulating, it can be difficult to know what is a realistic treatment option and what is simply hype.

As someone who spent 12 years working within NHS rheumatology and pain-management clinics, I have seen firsthand the frustration that comes with chronic pain. My goal here is to cut through the noise, explain how the UK system actually works, and clarify what these private services represent in the context of your broader health journey.
Understanding Arthritis and Standard NHS Care
Arthritis is not one single disease; it is an umbrella term for conditions that cause pain and inflammation in a joint. Whether you are dealing with osteoarthritis (the wear-and-tear type) or inflammatory conditions like rheumatoid arthritis or psoriatic arthritis, the management strategy is generally focused on three things: reducing inflammation, preserving joint function, and managing pain.

In the UK, the NHS follows established clinical guidelines—often set by NICE (the National Institute for Health and Care Excellence). Your standard care pathway usually includes:
Lifestyle adjustments: Weight management and low-impact exercise (often prescribed via social prescribing or physiotherapy). Analgesia: Starting with paracetamol and moving toward Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) like ibuprofen or naproxen. Physiotherapy: Tailored exercises to strengthen the muscles supporting the joint. Disease-Modifying Antirheumatic Drugs (DMARDs) or Biologics: For inflammatory arthritis, these are the gold standard to prevent long-term joint damage.
The NHS approach is built on evidence-based medicine. This means treatments are only recommended once they have been proven both safe and effective through large-scale clinical trials. This is a crucial distinction to remember when exploring private alternatives.
What is Releaf and the Role of Private Providers?
You may have encountered releaf.co.uk arthritis page while searching for alternative ways to manage persistent joint pain. It is important to define what this service is: Releaf acts as a private clinic platform that connects patients with specialist consultants who are registered to prescribe medical cannabis.

Unlike standard NHS services, which are free at the point of use and governed by national commissioning groups, private providers operate as independent entities. They provide a route for patients who have already exhausted standard NHS treatment pathways and are looking to see if medicinal cannabis products might offer symptom relief.

However, it is vital to avoid the "miracle cure" trap. Medical cannabis for arthritis is not a replacement for DMARDs or physiotherapy; rather, it is viewed by some as an adjunct therapy for those whose pain remains refractory (unresponsive) to traditional, first-line treatments.
The 2018 Law Change: Why the Confusion?
There is often confusion about why medical cannabis is "legal" but still so hard to get on the NHS. In November 2018, the UK government changed the law, moving cannabis-based products for medicinal use (CBPMs) from Schedule 1 to Schedule 2 under the Misuse of Drugs Regulations 2001.

As detailed in House of Commons Library research briefings, this change meant that specialist doctors—but not GPs—could legally prescribe cannabis-based medicines. The catch, as noted by the NHS England website, is that these prescriptions are only recommended on the NHS in very specific cases, such as rare forms of epilepsy, chemotherapy-induced nausea, or spasticity related to multiple sclerosis.

Because the clinical evidence for arthritis remains limited or is not yet robust enough to meet the strict cost-effectiveness criteria of the NHS, you will almost never be offered this via a GP or NHS consultant. This is why private clinics have emerged to fill the gap, operating within the letter of the law but outside the NHS funding structure.
Who Can Prescribe Medical Cannabis?
In the UK, the law is very specific about who can initiate these prescriptions. It is not something a pharmacist or a GP can sign off on. Prescribing is restricted to:
Specialist Consultants: They must be listed on the General Medical Council (GMC) Specialist Register. Practitioners in a Private Clinic: Many clinics employ doctors who specialise in pain management or psychiatry to review patient eligibility.
If you see a clinic promising a prescription without a rigorous medical assessment from a specialist consultant, proceed with extreme caution. Legitimate providers will always require your medical history, including evidence that you have tried standard treatments first.
Eligibility Checklist
Before you consider looking into private providers, you need to meet the criteria typically required for a consultation:
Criterion Requirement Treatment History You must have already tried at least two licensed medications or therapies (e.g., NSAIDs, physiotherapy) without success. Medical History You must provide your Summary Care Record (SCR) from your GP. Assessment A consultation with a specialist consultant who will weigh the risks vs. benefits. Monitoring You must be willing to undergo follow-up reviews to track efficacy and side effects. Managing Expectations
As a former clinic admin, I cannot stress this enough: be wary of providers that make vague, sweeping claims about "curing" arthritis or "eradicating" pain. Medical cannabis is a complex therapeutic area. It may help some patients with pain modulation, sleep, or secondary anxiety related to chronic pain, but it is not a magic wand.

Furthermore, because it is private, the cost can be significant. You are paying for the consultation, the prescribing doctor’s time, and the medication itself, which is not subsidised by the NHS. Always factor the long-term financial commitment into your decision-making process.
What Happens Next?
If you are frustrated with your current arthritis management and feel you have reached a plateau, here is the professional, step-by-step approach I recommend:
Review your current NHS care: Schedule an appointment with your GP or rheumatologist. Ask, "I’ve tried these treatments for X months/years; is there anything else in the current NHS pathway I haven’t tried?" Document your treatments: Create a list of every medication, injection, or physical therapy you have attempted. This is vital for any future private consultation. Check the NHS England guidance: Visit the official NHS England website to ensure you understand the current clinical position on cannabis-based medicines. Consultation: If you decide to explore a private route like Releaf, do not jump into a payment. Book an initial consultation to discuss your specific arthritis type and history with a qualified consultant. If they do not ask for your medical records, walk away. Monitor: If you do begin a new treatment, keep a pain diary for four weeks. This helps you and your doctor objectively assess whether the treatment is actually helping or if you are simply experiencing a placebo effect.
Navigating the world of private health can feel overwhelming, but staying informed is your best defence. Stick to established providers, ensure you have a clear paper trail https://doctiplus.net/arthritis-and-medical-cannabis-can-uk-patients-get-a-prescription/ of your treatment history, and always prioritise your long-term relationship with your primary NHS care team.